+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Global Flow Cytometry Market Size, Share & Trends Analysis Report by Product (Instruments, Software), Technology (Bead-based, Cell-based), Application (Industrial, Clinical), End-use, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 166 Pages
  • June 2024
  • Region: Global
  • Grand View Research
  • ID: 4118843
The global flow cytometry market size is expected to reach USD 7.01 billion by 2030, registering a CAGR of 6.96% over the forecast period. Technological advancements in the technique are introducing new and improved analytical tools, which include the development of microfluidic flow cytometry for Point-of-Care (PoC) testing. Furthermore, the rising prevalence of cancer, immunodeficiency disorders, and infectious diseases is driving the industry. In addition, increasing R&D investments in biopharmaceutical, life science, and biotechnology research activities have led to high demand for flow cytometry instruments. In recent years, a key focus has been on the development of portable microfluidic flow cytometry devices for PoC testing.

Microfluidics and flow cytometry together make a useful tool to measure multiple characteristics of biological samples. For instance, the easy availability of several microfluidics and miniaturized detectors have enabled the creation of microchip-based cytometers, such as optofluidic cytometer, imaging cytometer, and impedance cytometer. The development of microfluidic flow cytometry devices, which are cost-effective, portable, and compact, is beneficial. They are affordable in developing economies, such as Asia & Africa, and are enabling rapid growth in PoC testing applications. Furthermore, improvements in fluorescent dyes and the increasing utility of benchtop cytometers for academic research settings are expected to drive the industry.

Developments in multicolor flow cytometry are accelerating the adoption of the technique in novel drug development activities. For instance, in January 2020, DxFLEX, CE-IVD, a 13-colour clinical flow cytometry system was launched by Beckman Coulter Life Sciences in Europe. Similarly, easy cellular analysis by simultaneous evaluation of several parameters allows extensive use of such devices for contract research purposes. The COVID-19 pandemic also spurred innovations in the technique, as evidenced by the launch of new products in this domain. For instance, in July 2021, Metropolis Healthcare Ltd. launched CoviRisk-TBNK, a simple blood test to detect the risk status of a COVID-19 hospitalized patient.

It helps analyze patients’ need for ICU facilities or ventilation and aids in the reduction of stress on healthcare resources. The test is a flow cytometry-based lymphocyte subset assay and is IVD-approved. Such innovations are anticipated to fuel industry growth in the near future. Moreover, flow cytometry is a significant tool in listing and characterizing immune cells, and is also helpful in recognizing and validating underlying genetic defects. The technique is also used to observe and monitor the immune response of patients after stem cell transplantation, and hence, organ transplantation plays an important role in boosting industry growth. According to the WHO, around 50,000 stem cell transplantations are performed globally every year, and this number is expected to grow in the near future, broadening the scope of applications for the technique.

On the other hand, instruments are highly expensive, and hence, buyers in several developing countries may not be able to afford technologically advanced flow cytometry equipment. These instruments may cost over USD 100,000 and pose significant budgetary constraints for small- & mid-sized hospitals and clinical laboratories. However, some manufacturers, such as Sony, are trying to launch newer instruments using software to automate a number of processes. Such developments would not only improve the usability of the technique but also help bring down the average instrumentation cost-under USD 100,000-in the near future.

Flow Cytometry Market Report Highlights

  • The instrument product segment held the largest share in 2023 due to technical advancements, as well as increased prevalence of chronic conditions
  • The cell-based flow cytometry technology dominated the industry in 2023 due to the high demand for early diagnosis and rising awareness about the associated benefits of cell-based assays
  • By application, the clinical segment accounted for the largest revenue share in 2023 owing to increased activities pertaining to infectious diseases, such as influenza, HIV, and COVID-19, among others
  • The academic institutes end-user segment led the market in 2023 owing to increased R&D activities by academic institutes & research centers
  • North America was the leading region in 2023 due to the high implementation of scientifically advanced flow cytometry solutions, high healthcare expenditure, and well-established healthcare infrastructure in the region
  • Asia Pacific is expected to register the fastest CAGR from 2022 to 2030 owing to the extensive growth in the pharmaceutical and biotechnology industries in emerging economies, such as China and India

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.1.1 Regional Scope
1.1.2 Market Definitions
1.1.3 Estimates And Forecast Timeline
1.2 Objectives
1.2.1 Objective - 1
1.2.2 Objective - 2
1.2.3 Objective - 3
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 GVR’s Internal Database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.4.5 Details Of Primary Research
1.5 Information or Data Analysis
1.5.1 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Commodity Flow Analysis
1.7.1.1 Approach 1: Commodity Flow Approach
1.7.1.2 Approach 2: Country wise market estimation using bottom-up approach
1.8 List of Secondary Sources
1.9 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Product and Technology Segment Snapshot
2.3 Application and End-use Segment Snapshot
2.4 Competitive Landscape Snapshot
Chapter 3 Market Variables, Trends, and Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Growing prevalence of chronic and infectious diseases
3.2.1.2 High R&D investments in biotechnology, clinical, and life science research
3.2.1.3 Technological advancements in flow cytometry instruments and reagents
3.2.1.4 Increasing demand for point-of-care diagnostics
3.2.2 Market Restraint Analysis
3.2.2.1 High Cost Of Instruments
3.2.3 Industry Challenges
3.2.3.1 Low Cell Throughput Rate
3.3 Business Environment Analysis
3.3.1 Pestel Analysis
3.3.2 Porter’s Five Forces Analysis
3.4 COVID-19 Impact Analysis
Chapter 4 Flow Cytometry Market - Segment Analysis, by Product, 2018-2030 (USD Million)
4.1 Flow Cytometry Market: Product Movement Analysis
4.2 Flow Cytometry Market Estimates & Forecast by Product (USD Million)
4.2.1 Instruments
4.2.1.1 Cell Analyzers
4.2.1.2 Cell Sorters
4.2.2 Reagents & Consumables
4.2.3 Software
4.2.4 Accessories
4.2.5 Services
Chapter 5 Flow Cytometry Market - Segment Analysis, by Technology, 2018-2030 (USD Million)
5.1 Flow Cytometry Market: Technology Movement Analysis
5.2 Flow Cytometry Market Estimates & Forecast by Technology (USD Million)
5.2.1 Cell-Based
5.2.2 Bead-Based
Chapter 6 Flow Cytometry Market - Segment Analysis, by Application, 2018-2030 (USD Million)
6.1 Flow Cytometry Market: Application Movement Analysis
6.2 Flow Cytometry Market Estimates & Forecast by Application (USD Million)
6.2.1 Research
6.2.1.1 Pharmaceutical
6.2.1.1.1 Drug Discovery
6.2.1.1.2 Stem Cell
6.2.1.1.3 In Vitro Toxicity
6.2.1.2 Apoptosis
6.2.1.3 Cell Sorting
6.2.1.4 Cell Cycle Analysis
6.2.1.5 Immunology
6.2.1.6 Cell Viability
6.2.2 Industrial
6.2.3 Clinical
6.2.3.1 Cancer
6.2.3.2 Organ Transplantation
6.2.3.3 Immunodeficiency
6.2.3.4 Hematology
6.2.3.5 Autoimmune Disorders
Chapter 7 Flow Cytometry Market - Segment Analysis, by End Use, 2018-2030 (USD Million)
7.1 Flow Cytometry Market: End-use Movement Analysis
7.2 Flow Cytometry Market Estimates & Forecast by End Use (USD Million)
7.2.1 Commercial Organizations
7.2.1.1 Biotechnology Companies
7.2.1.2 Pharmaceutical Companies
7.2.1.3 Cros
7.2.2 Hospitals
7.2.3 Academic Institutes
7.2.4 Clinical Testing Labs
Chapter 8 Flow Cytometry Market: Regional Estimates and Trend Analysis, By Product, Technology, Application, and End Use
8.1 Flow Cytometry Market: Regional Outlook
8.2 North America
8.2.1 North America Flow Cytometry Market Estimates And Forecasts, 2018-2030 (USD Million)
8.2.2 U.S.
8.2.2.1 Key Country Dynamics
8.2.2.2 U.S. Flow Cytometry Market Estimates And Forecasts, 2018-2030 (USD Million)
8.2.2.3 Competitive/Market Scenario
8.2.2.4 Regulatory Framework
8.2.2.5 Reimbursement Scenario
8.2.3 Canada
8.2.3.1 Key Country Dynamics
8.2.3.2 Canada flow cytometry market estimates and forecasts, 2018-2030 (USD Million)
8.2.3.3 Competitive/Market Scenario
8.2.3.4 Regulatory Framework
8.2.3.5 Reimbursement Scenario
8.3 Europe
8.3.1 Europe Flow Cytometry Market Estimates And Forecasts, 2018-2030 (USD Million)
8.3.2 UK
8.3.2.1 Key Country Dynamics
8.3.2.2 UK Flow Cytometry Market Estimates And Forecasts, 2018-2030 (USD Million)
8.3.2.3 Competitive/Market Scenario
8.3.2.4 Regulatory Framework
8.3.2.5 Reimbursement Scenario
8.3.3 Germany
8.3.3.1 Key Country Dynamics
8.3.3.2 Germany Flow Cytometry Market Estimates And Forecasts, 2018-2030 (USD Million)
8.3.3.3 Competitive/Market Scenario
8.3.3.4 Regulatory Framework
8.3.3.5 Reimbursement Scenario
8.3.4 France
8.3.4.1 Key Country Dynamics
8.3.4.2 France Flow Cytometry Market Estimates And Forecasts, 2018-2030 (USD Million)
8.3.4.3 Competitive Scenario
8.3.4.4 Regulatory Framework
8.3.4.5 Reimbursement Scenario
8.3.5 Italy
8.3.5.1 Key Country Dynamics
8.3.5.2 Italy Flow Cytometry Market Estimates And Forecasts, 2018-2030 (USD Million)
8.3.5.3 Competitive/Market Scenario
8.3.5.4 Regulatory Framework
8.3.5.5 Reimbursement Scenario
8.3.6 Spain
8.3.6.1 Key Country Dynamics
8.3.6.2 Spain Flow Cytometry Market Estimates And Forecasts, 2018-2030 (USD Million)
8.3.6.3 Competitive/Market Scenario
8.3.6.4 Regulatory Framework
8.3.6.5 Reimbursement Scenario
8.3.7 Denmark
8.3.7.1 Key Country Dynamics
8.3.7.2 Denmark Flow Cytometry Market Estimates And Forecasts, 2018-2030 (USD Million)
8.3.7.3 Competitive/Market Scenario
8.3.7.4 Regulatory Framework
8.3.7.5 Reimbursement Scenario
8.3.8 Sweden
8.3.8.1 Key Country Dynamics
8.3.8.2 Sweden Flow Cytometry Market Estimates And Forecasts, 2018-2030 (USD Million)
8.3.8.3 Competitive/Market Scenario
8.3.8.4 Regulatory Framework
8.3.9 Norway
8.3.9.1 Key Country Dynamics
8.3.9.2 Norway Flow Cytometry Market Estimates And Forecasts, 2018-2030 (USD Million)
8.3.9.3 Competitive/Market Scenario
8.3.9.4 Regulatory Framework
8.3.9.5 Reimbursement Scenario
8.3.10 Rest Of Europe Flow Cytometry Market Estimates And Forecasts, 2018-2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Flow Cytometry Market Estimates And Forecasts, 2018-2030 (USD Million)
8.4.2 Japan
8.4.2.1 Key Country Dynamics
8.4.2.2 Japan Flow Cytometry Market Estimates And Forecasts, 2018-2030 (USD Million)
8.4.2.3 Competitive/Market Scenario
8.4.2.4 Regulatory Framework
8.4.2.5 Reimbursement Scenario
8.4.3 China
8.4.3.1 Key Country Dynamics
8.4.3.2 China Flow Cytometry Market Estimates And Forecasts, 2018-2030 (USD Million)
8.4.3.3 Competitive/Market Scenario
8.4.3.4 Regulatory Framework
8.4.3.5 Reimbursement Scenario
8.4.4 India
8.4.4.1 Key Country Dynamics
8.4.4.2 India Flow Cytometry Market Estimates And Forecasts, 2018-2030 (USD Million)
8.4.4.3 Competitive/Market Scenario
8.4.4.4 Regulatory Framework
8.4.4.5 Reimbursement Scenario
8.4.5 Australia
8.4.5.1 Key Country Dynamics
8.4.5.2 Australia Flow Cytometry Market Estimates And Forecasts, 2018-2030 (USD Million)
8.4.5.3 Competitive/Market Scenario
8.4.5.4 Regulatory Framework
8.4.5.5 Reimbursement Scenario
8.4.6 Thailand
8.4.6.1 Key Country Dynamics
8.4.6.2 Thailand Flow Cytometry Market Estimates And Forecasts, 2018-2030 (USD Million)
8.4.6.3 Competitive/Market Scenario
8.4.6.4 Regulatory Framework
8.4.6.5 Reimbursement Scenario
8.4.7 South Korea
8.4.7.1 Key Country Dynamics
8.4.7.2 South Korea Flow Cytometry Market Estimates And Forecasts, 2018-2030 (USD Million)
8.4.7.3 Competitive/Market Scenario
8.4.7.4 Regulatory Framework
8.4.7.5 Reimbursement Scenario
8.4.8 Singapore
8.4.8.1 Key Country Dynamics
8.4.8.2 Singapore Flow Cytometry Market Estimates And Forecasts, 2018-2030 (USD Million)
8.4.8.3 Competitive Scenario
8.4.8.4 Regulatory Framework
8.4.8.5 Reimbursement Scenario
8.4.9 Rest Of Asia Pacific Flow Cytometry Market Estimates And Forecasts, 2018-2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Flow Cytometry Market Estimates And Forecasts, 2018-2030, (USD Million)
8.5.2 Brazil
8.5.2.1 Key Country Dynamics
8.5.2.2 Brazil Flow Cytometry Market Estimates And Forecasts, 2018-2030, (USD Million)
8.5.2.3 Competitive/Market Scenario
8.5.2.4 Regulatory Framework
8.5.2.5 Reimbursement Scenario
8.5.3 Mexico
8.5.3.1 Key Country Dynamics
8.5.3.2 Mexico Flow Cytometry Market Estimates And Forecasts, 2018-2030, (USD Million)
8.5.3.3 Competitive/Market Scenario
8.5.3.4 Regulatory Framework
8.5.3.5 Reimbursement Scenario
8.5.4 Argentina
8.5.4.1 Key Country Dynamics
8.5.4.2 Argentina Flow Cytometry Market Estimates And Forecasts, 2018-2030, (USD Million)
8.5.4.3 Competitive/Market Scenario
8.5.4.4 Regulatory Framework
8.5.4.5 Rest of Latin America Flow Cytometry Market Estimates And Forecasts, 2018-2030, (USD Million)
8.6 MEA
8.6.1 MEA Flow Cytometry Market Estimates And Forecasts, 2018-2030, (USD Million)
8.6.2 South Africa
8.6.2.1 Key Country Dynamics
8.6.2.2 South Africa Flow Cytometry Market Estimates and Forecasts, 2018-2030, (USD Million)
8.6.2.3 Competitive Scenario
8.6.2.4 Regulatory Framework
8.6.2.5 Reimbursement Scenario
8.6.3 Saudi Arabia
8.6.3.1 Key Country Dynamics
8.6.3.2 Saudi Arabia Flow Cytometry Market Estimates and Forecasts, 2018-2030, (USD Million)
8.6.3.3 Competitive Scenario
8.6.3.4 Regulatory Framework
8.6.3.5 Reimbursement Scenario
8.6.4 UAE
8.6.4.1 Key Country Dynamics
8.6.4.2 UAE Flow Cytometry Market Estimates and Forecasts, 2018-2030, (USD Million)
8.6.4.3 Competitive Scenario
8.6.4.4 Regulatory Framework
8.6.4.5 Reimbursement Scenario
8.6.5 Kuwait
8.6.5.1 Key Country Dynamics
8.6.5.2 Kuwait Flow Cytometry Market Estimates and Forecasts, 2018-2030, (USD Million)
8.6.5.3 Competitive Scenario
8.6.5.4 Regulatory Framework
8.6.5.5 Reimbursement Scenario
8.6.6 Rest Of Mea Flow Cytometry Market Estimates And Forecasts, 2018-2030 (USD Million)
Chapter 9 Competitive Landscape
9.1 Company Profiles
9.7.1 DANAHER CORPORATION
9.7.1.1 Company overview
9.7.1.2 Beckman Coulter, Inc.
9.7.1.2.1 Company Overview
9.7.1.3 Cytiva
9.7.1.3.1 Company Overview
9.7.1.4 Financial performance
9.7.1.5 Product benchmarking
9.7.1.6 Strategic initiatives
9.7.2 BECTON, DICKINSON AND COMPANY (BD)
9.7.2.1 Company overview
9.7.2.2 Financial performance
9.7.2.3 Product benchmarking
9.7.2.4 Strategic initiatives
9.7.3 SYSMEX CORPORATION
9.7.3.1 Company overview
9.7.3.2 Financial performance
9.7.3.3 Product benchmarking
9.7.3.4 Strategic initiatives
9.7.4 AGILENT TECHNOLOGIES, INC.
9.7.4.1 Company overview
9.7.4.2 Financial performance
9.7.4.3 Product benchmarking
9.7.4.4 Strategic initiatives
9.7.5 APOGEE FLOW SYSTEMS LTD.
9.7.5.1 Company overview
9.7.5.2 Product benchmarking
9.7.5.3 Strategic initiatives
9.7.6 BIO-RAD LABORATORIES, INC.
9.7.6.1 Company overview
9.7.6.2 Financial performance
9.7.6.3 Product benchmarking
9.7.6.4 Strategic initiatives
9.7.7 THERMO FISHER SCIENTIFIC, INC.
9.7.7.1 Company overview
9.7.7.2 Financial performance
9.7.7.3 Product benchmarking
9.7.7.4 Strategic initiatives
9.7.8 STRATEDIGM, INC.
9.7.8.1 Company overview
9.7.8.2 Product benchmarking
9.2 Company Categorization
9.3 Flow cytometry Market Share Analysis, 2023
9.4 Strategy Mapping
9.4.1 Mergers & Acquisitions
9.4.2 Partnerships And Collaborations
9.4.3 New Product Launch
9.4.4 Others
Chapter 10 Conclusion
List of Tables
Table 1 List of secondary sources
Table 2 Regulatory status and recommended validation strategy for flow cytometry assays
Table 3 CPT codes for flow cytometry reimbursement
Table 4 Global flow cytometry market, by product, 2018-2030 (USD Million)
Table 5 Global flow cytometry market, by technology, 2018-2030 (USD Million)
Table 6 Global flow cytometry market, application, 2018-2030 (USD Million)
Table 7 Global flow cytometry market, end-use, 2018-2030 (USD Million)
Table 8 Global flow cytometry market, by region, 2018-2030 (USD Million)
Table 9 North America flow cytometry market, by country, 2018-2030 (USD Million)
Table 10 North America flow cytometry market, by product, 2018-2030 (USD Million)
Table 11 North America flow cytometry market, by technology, 2018-2030 (USD Million)
Table 12 North America flow cytometry market, application, 2018-2030 (USD Million)
Table 13 North America flow cytometry market, end-use, 2018-2030 (USD Million)
Table 14 U.S. Flow cytometry market, by product, 2018-2030 (USD Million)
Table 15 U.S. Flow cytometry market, by technology, 2018-2030 (USD Million)
Table 16 U.S. Flow cytometry market, application, 2018-2030 (USD Million)
Table 17 U.S. Flow cytometry market, end-use, 2018-2030 (USD Million)
Table 18 Canada flow cytometry market, by product, 2018-2030 (USD Million)
Table 19 Canada flow cytometry market, by technology, 2018-2030 (USD Million)
Table 20 Canada flow cytometry market, application, 2018-2030 (USD Million)
Table 21 Canada flow cytometry market, end-use, 2018-2030 (USD Million)
Table 22 Europe flow cytometry market, by country, 2018-2030 (USD Million)
Table 23 Europe flow cytometry market, by product, 2018-2030 (USD Million)
Table 24 Europe flow cytometry market, by technology, 2018-2030 (USD Million)
Table 25 Europe flow cytometry market, application, 2018-2030 (USD Million)
Table 26 Europe flow cytometry market, end-use, 2018-2030 (USD Million)
Table 27 Germany flow cytometry market, by product, 2018-2030 (USD Million)
Table 28 Germany flow cytometry market, by technology, 2018-2030 (USD Million)
Table 29 Germany flow cytometry market, application, 2018-2030 (USD Million)
Table 30 Germany flow cytometry market, end-use, 2018-2030 (USD Million)
Table 31 U.K. flow cytometry market, by product, 2018-2030 (USD Million)
Table 32 U.K. flow cytometry market, by technology, 2018-2030 (USD Million)
Table 33 U.K. flow cytometry market, application, 2018-2030 (USD Million)
Table 34 U.K. flow cytometry market, end-use, 2018-2030 (USD Million)
Table 35 France flow cytometry market, by product, 2018-2030 (USD Million)
Table 36 France flow cytometry market, by technology, 2018-2030 (USD Million)
Table 37 France flow cytometry market, application, 2018-2030 (USD Million)
Table 38 France flow cytometry market, end-use, 2018-2030 (USD Million)
Table 39 Italy flow cytometry market, by product, 2018-2030 (USD Million)
Table 40 Italy flow cytometry market, by technology, 2018-2030 (USD Million)
Table 41 Italy flow cytometry market, application, 2018-2030 (USD Million)
Table 42 Italy flow cytometry market, end-use, 2018-2030 (USD Million)
Table 43 Spain flow cytometry market, by product, 2018-2030 (USD Million)
Table 44 Spain flow cytometry market, by technology, 2018-2030 (USD Million)
Table 45 Spain flow cytometry market, application, 2018-2030 (USD Million)
Table 46 Spain flow cytometry market, end-use, 2018-2030 (USD Million)
Table 47 Denmark flow cytometry market, by product, 2018-2030 (USD Million)
Table 48 Denmark flow cytometry market, by technology, 2018-2030 (USD Million)
Table 49 Denmark flow cytometry market, application, 2018-2030 (USD Million)
Table 50 Denmark flow cytometry market, end-use, 2018-2030 (USD Million)
Table 51 Sweden flow cytometry market, by product, 2018-2030 (USD Million)
Table 52 Sweden flow cytometry market, by technology, 2018-2030 (USD Million)
Table 53 Sweden flow cytometry market, application, 2018-2030 (USD Million)
Table 54 Sweden flow cytometry market, end-use, 2018-2030 (USD Million)
Table 55 Norway flow cytometry market, by product, 2018-2030 (USD Million)
Table 56 Norway flow cytometry market, by technology, 2018-2030 (USD Million)
Table 57 Norway flow cytometry market, application, 2018-2030 (USD Million)
Table 58 Norway flow cytometry market, end-use, 2018-2030 (USD Million)
Table 59 Asia pacific flow cytometry market, by country, 2018-2030 (USD Million)
Table 60 Asia pacific flow cytometry market, by product, 2018-2030 (USD Million)
Table 61 Asia pacific flow cytometry market, by technology, 2018-2030 (USD Million)
Table 62 Asia pacific flow cytometry market, application, 2018-2030 (USD Million)
Table 63 Asia pacific flow cytometry market, end-use, 2018-2030 (USD Million)
Table 64 China flow cytometry market, by product, 2018-2030 (USD Million)
Table 65 China flow cytometry market, by technology, 2018-2030 (USD Million)
Table 66 China flow cytometry market, application, 2018-2030 (USD Million)
Table 67 China flow cytometry market, end-use, 2018-2030 (USD Million)
Table 68 India flow cytometry market, by product, 2018-2030 (USD Million)
Table 69 India flow cytometry market, by technology, 2018-2030 (USD Million)
Table 70 India flow cytometry market, application, 2018-2030 (USD Million)
Table 71 India flow cytometry market, end-use, 2018-2030 (USD Million)
Table 72 Japan flow cytometry market, by product, 2018-2030 (USD Million)
Table 73 Japan flow cytometry market, by technology, 2018-2030 (USD Million)
Table 74 Japan flow cytometry market, application, 2018-2030 (USD Million)
Table 75 Japan flow cytometry market, end-use, 2018-2030 (USD Million)
Table 76 South Korea flow cytometry market, by product, 2018-2030 (USD Million)
Table 77 South Korea flow cytometry market, by technology, 2018-2030 (USD Million)
Table 78 South Korea flow cytometry market, application, 2018-2030 (USD Million)
Table 79 South Korea flow cytometry market, end-use, 2018-2030 (USD Million)
Table 80 Australia flow cytometry market, by product, 2018-2030 (USD Million)
Table 81 Australia flow cytometry market, by technology, 2018-2030 (USD Million)
Table 82 Australia flow cytometry market, application, 2018-2030 (USD Million)
Table 83 Australia flow cytometry market, end-use, 2018-2030 (USD Million)
Table 84 Thailand flow cytometry market, by product, 2018-2030 (USD Million)
Table 85 Thailand flow cytometry market, by technology, 2018-2030 (USD Million)
Table 86 Thailand flow cytometry market, application, 2018-2030 (USD Million)
Table 87 Thailand flow cytometry market, end-use, 2018-2030 (USD Million)
Table 88 Singapore flow cytometry market, by product, 2018-2030 (USD Million)
Table 89 Singapore flow cytometry market, by technology, 2018-2030 (USD Million)
Table 90 Singapore flow cytometry market, application, 2018-2030 (USD Million)
Table 91 Singapore flow cytometry market, end-use, 2018-2030 (USD Million)
Table 92 Latin America flow cytometry market, by country, 2018-2030 (USD Million)
Table 93 Latin America flow cytometry market, by product, 2018-2030 (USD Million)
Table 94 Latin America flow cytometry market, by technology, 2018-2030 (USD Million)
Table 95 Latin America flow cytometry market, application, 2018-2030 (USD Million)
Table 96 Latin America flow cytometry market, end-use, 2018-2030 (USD Million)
Table 97 Brazil flow cytometry market, by product, 2018-2030 (USD Million)
Table 98 Brazil flow cytometry market, by technology, 2018-2030 (USD Million)
Table 99 Brazil flow cytometry market, application, 2018-2030 (USD Million)
Table 100 Brazil flow cytometry market, end-use, 2018-2030 (USD Million)
Table 101 Mexico flow cytometry market, by product, 2018-2030 (USD Million)
Table 102 Mexico flow cytometry market, by technology, 2018-2030 (USD Million)
Table 103 Mexico flow cytometry market, application, 2018-2030 (USD Million)
Table 104 Mexico flow cytometry market, end-use, 2018-2030 (USD Million)
Table 105 Argentina flow cytometry market, by product, 2018-2030 (USD Million)
Table 106 Argentina flow cytometry market, by technology, 2018-2030 (USD Million)
Table 107 Argentina flow cytometry market, application, 2018-2030 (USD Million)
Table 108 Argentina flow cytometry market, end-use, 2018-2030 (USD Million)
Table 109 Middle east & Africa flow cytometry market, by country, 2018-2030 (USD Million)
Table 110 Middle east & Africa flow cytometry market, by product, 2018-2030 (USD Million)
Table 111 Middle east & Africa flow cytometry market, by technology, 2018-2030 (USD Million)
Table 112 Middle east & Africa flow cytometry market, application, 2018-2030 (USD Million)
Table 113 Middle east & Africa flow cytometry market, end-use, 2018-2030 (USD Million)
Table 114 South Africa flow cytometry market, by product, 2018-2030 (USD Million)
Table 115 South Africa flow cytometry market, by technology, 2018-2030 (USD Million)
Table 116 South Africa flow cytometry market, application, 2018-2030 (USD Million)
Table 117 South Africa flow cytometry market, end-use, 2018-2030 (USD Million)
Table 118 Saudi Arabia flow cytometry market, by product, 2018-2030 (USD Million)
Table 119 Saudi Arabia flow cytometry market, by technology, 2018-2030 (USD Million)
Table 120 Saudi Arabia flow cytometry market, application, 2018-2030 (USD Million)
Table 121 Saudi Arabia flow cytometry market, end-use, 2018-2030 (USD Million)
Table 122 UAE flow cytometry market, by product, 2018-2030 (USD Million)
Table 123 UAE flow cytometry market, by technology, 2018-2030 (USD Million)
Table 124 UAE flow cytometry market, application, 2018-2030 (USD Million)
Table 125 UAE flow cytometry market, end-use, 2018-2030 (USD Million)
Table 126 Kuwait flow cytometry market, by product, 2018-2030 (USD Million)
Table 127 Kuwait flow cytometry market, by technology, 2018-2030 (USD Million)
Table 128 Kuwait flow cytometry market, application, 2018-2030 (USD Million)
Table 129 Kuwait flow cytometry market, end-use, 2018-2030 (USD Million)
Table 130 Company Market Share Analysis, 2023
List of Figures
Figure 1 Flow cytometry market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Value chain based sizing & forecasting
Figure 6 QFD modelling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Market snapshot
Figure 9 Product and technology segment snapshot
Figure 10 Application and end-use segment snapshot
Figure 11 Competitive landscape snapshot
Figure 12 Life science tools market value, 2023 (USD Billion)
Figure 13 Market dynamics
Figure 14 PESTEL analysis
Figure 15 Porter’s five forces analysis
Figure 16 Flow cytometry market: Product outlook and key takeaways
Figure 17 Flow cytometry market: Product movement analysis
Figure 18 Instruments market estimates and forecast, 2018-2030 (USD Million)
Figure 19 Cell analyzers market estimates and forecast, 2018-2030 (USD Million)
Figure 20 Cell sorters market estimates and forecast, 2018-2030 (USD Million)
Figure 21 Reagents & consumables market estimates and forecast, 2018-2030 (USD million)
Figure 22 Software market estimates and forecast, 2018-2030 (USD million)
Figure 23 Accessories market estimates and forecast, 2018-2030 (USD million)
Figure 24 Services market estimates and forecast, 2018-2030 (USD million)
Figure 25 Flow cytometry market: Technology outlook and key takeaways
Figure 26 Flow cytometry market: Technology movement analysis
Figure 27 Cell-based market estimates and forecast, 2018-2030 (USD Million)
Figure 28 Bead-based market estimates and forecast, 2018-2030 (USD Million)
Figure 29 Flow cytometry market: Application outlook and key takeaways
Figure 30 Flow cytometry market: Application movement analysis
Figure 31 Research market estimates and forecast, 2018-2030 (USD Million)
Figure 32 Pharmaceutical market estimates and forecast, 2018-2030 (USD Million)
Figure 33 Drug discovery market estimates and forecast, 2018-2030 (USD Million)
Figure 34 Stem cell market estimates and forecast, 2018-2030 (USD Million)
Figure 35 In vitro toxicity market estimates and forecast, 2018-2030 (USD Million)
Figure 36 Apoptosis market estimates and forecast, 2018-2030 (USD Million)
Figure 37 Cell sorting market estimates and forecast, 2018-2030 (USD Million)
Figure 38 Cell cycle analysis market estimates and forecast, 2018-2030 (USD Million)
Figure 39 Immunology market estimates and forecast, 2018-2030 (USD Million)
Figure 40 Cell viability market estimates and forecast, 2018-2030 (USD Million)
Figure 41 Industrial market estimates and forecast, 2018-2030 (USD Million)
Figure 42 Clinical market estimates and forecast, 2018-2030 (USD Million)
Figure 43 Cancer market estimates and forecast, 2018-2030 (USD Million)
Figure 44 Organ transplantation market estimates and forecast, 2018-2030 (USD Million)
Figure 45 Immunodeficiency market estimates and forecast, 2018-2030 (USD Million)
Figure 46 Hematology market estimates and forecast, 2018-2030 (USD Million)
Figure 47 Autoimmune disorders market estimates and forecast, 2018-2030 (USD Million)
Figure 48 Flow cytometry market: End-use outlook and key takeaways
Figure 49 Flow cytometry market: End-use movement analysis
Figure 50 Commercial organizations market estimates and forecast, 2018-2030 (USD Million)
Figure 51 Biotechnology companies market estimates and forecast, 2018-2030 (USD Million)
Figure 52 Pharmaceutical companies market estimates and forecast, 2018-2030 (USD Million)
Figure 53 CROs market estimates and forecast, 2018-2030 (USD Million)
Figure 54 Hospitals market estimates and forecast, 2018-2030 (USD Million)
Figure 55 Academic institutes market estimates and forecast, 2018-2030 (USD Million)
Figure 56 Clinical testing labs market estimates and forecast, 2018-2030 (USD Million)
Figure 57 Flow cytometry market revenue, by region, 2023 & 2030 (USD Million)
Figure 58 Regional marketplace: Key takeaways
Figure 59 Regional marketplace: Key takeaways
Figure 60 North America market estimates and forecast, 2018-2030 (USD Million)
Figure 61 Key country dynamics
Figure 62 U.S. flow cytometry market estimates and forecast, 2018-2030 (USD Million)
Figure 63 Key country dynamics
Figure 64 Canada flow cytometry market estimates and forecast, 2018-2030 (USD Million)
Figure 65 Europe flow cytometry market estimates and forecast, 2018-2030 (USD Million)
Figure 66 Key country dynamics
Figure 67 UK flow cytometry market estimates and forecast, 2018-2030 (USD Million)
Figure 68 Key country dynamics
Figure 69 Germany flow cytometry market estimates and forecast, 2018-2030 (USD Million)
Figure 70 Key country dynamics
Figure 71 France flow cytometry market estimates and forecast, 2018-2030 (USD Million)
Figure 72 Key country dynamics
Figure 73 Italy flow cytometry market estimates and forecast, 2018-2030 (USD Million)
Figure 74 Key country dynamics
Figure 75 Spain flow cytometry market estimates and forecast, 2018-2030 (USD Million)
Figure 76 Key country dynamics
Figure 77 Denmark flow cytometry market estimates and forecast, 2018-2030 (USD Million)
Figure 78 Key country dynamics
Figure 79 Sweden flow cytometry market estimates and forecast, 2018-2030 (USD Million)
Figure 80 Key country dynamics
Figure 81 Norway flow cytometry market estimates and forecast, 2018-2030 (USD Million)
Figure 82 Rest of Europe market estimates and forecast, 2018-2030 (USD Million)
Figure 83 Asia Pacific flow cytometry market estimates and forecast, 2018-2030 (USD Million)
Figure 84 Key country dynamics
Figure 85 Japan flow cytometry market estimates and forecast, 2018-2030 (USD Million)
Figure 86 Key country dynamics
Figure 87 China flow cytometry market estimates and forecast, 2018-2030 (USD Million)
Figure 88 Key country dynamics
Figure 89 India flow cytometry market estimates and forecast, 2018-2030 (USD Million)
Figure 90 Key country dynamics
Figure 91 Australia flow cytometry market estimates and forecast, 2018-2030 (USD Million)
Figure 92 Key country dynamics
Figure 93 Thailand flow cytometry market estimates and forecast, 2018-2030 (USD Million)
Figure 94 Key country dynamics
Figure 95 South Korea flow cytometry market estimates and forecast, 2018-2030 (USD Million)
Figure 96 Key country dynamics
Figure 97 Singapore flow cytometry market estimates and forecast, 2018-2030 (USD Million)
Figure 98 Rest of Asia Pacific flow cytometry market estimates and forecast, 2018-2030 (USD Million)
Figure 99 Latin America flow cytometry market estimates and forecasts, 2018-2030 (USD Million)
Figure 100 Key country dynamics
Figure 101 Brazil flow cytometry market estimates and forecasts, 2018-2030 (USD Million)
Figure 102 Key country dynamics
Figure 103 Mexico flow cytometry market estimates and forecasts, 2018-2030 (USD Million)
Figure 104 Key country dynamics
Figure 105 Argentina flow cytometry market estimates and forecasts, 2018-2030 (USD Million)
Figure 106 Rest of Latin America flow cytometry market estimates and forecasts, 2018-2030 (USD Million)
Figure 107 MEA flow cytometry market estimates and forecasts, 2018-2030 (USD Million)
Figure 108 Key country dynamics
Figure 109 South Africa flow cytometry market estimates and forecasts, 2018-2030 (USD Million)
Figure 110 Key country dynamics
Figure 111 Saudi Arabia flow cytometry market estimates and forecasts, 2018-2030 (USD Million)
Figure 112 Key country dynamics
Figure 113 UAE flow cytometry market estimates and forecasts, 2018-2030 (USD Million)
Figure 114 Key country dynamics
Figure 115 Kuwait flow cytometry market estimates and forecasts, 2018-2030 (USD Million)
Figure 116 Rest of MEA flow cytometry market estimates and forecasts, 2018-2030 (USD Million)
Figure 117 Key company categorization
Figure 118 Flow cytometry market share analysis, 2023
Figure 119 Strategy mapping

Companies Mentioned

  • DANAHER CORPORATION
  • Beckman Coulter, Inc.
  • Cytiva
  • BECTON, DICKINSON AND COMPANY (BD)
  • SYSMEX CORPORATION
  • AGILENT TECHNOLOGIES, INC.
  • APOGEE FLOW SYSTEMS LTD.
  • BIO-RAD LABORATORIES, INC.
  • THERMO FISHER SCIENTIFIC, INC.
  • STRATEDIGM, INC.

Methodology

Loading
LOADING...

Table Information